Spread This NewsBy Gamuchirai Masiyiwa, GPJ Zimbabwe This story was originally published by Global Press Journal. ZVISHAVANE, ZIMBABWE — Morning light slants through the window as Eneles Zhou inspects ...

Martin Mwita, 20, is the first patient in St. Louis and among the first across the country to receive a new gene therapy for ...

Sickle cell disease is a chronic, inherited blood disorder that affects millions of people worldwide.It is characterised by the production of abnormally shaped red blood cells, which can block blood ...

One of the Trump administration’s top health officials said Friday that the federal government is working to expand access to ...

Robert F. Kennedy Jr. announces sickle-cell treatment program in Charleston while assuring SC Sen. Tim Scott that federal ...

Sickle cell has been overlooked for far too long. Fortunately, there are new breakthroughs in sickle cell treatment that you can't miss.

Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Calvin Dickey Jr.'s parents have sued Bucknell following his death two days after a 2024 football team workout. How can ...

Columnist Mary Shaniqua offers examples of some symptoms of sickle cell that are lesser known than fatigue and a ...

“Our results reinforce that hydroxyurea, the most efficacious medicine available for sickle cell disease, continues to have ...

With 26.6% of the European market share in 2022, the U.K. is recognized as a lucrative market for cell therapy manufacturing. Support from regulatory bodies like the European Medicines Agency (EMA) ...